Olema Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Alright, there we go. I think we're ready to start. I'm very excited to kick off the last session with a topic that I just find so interesting and often misunderstood. I'm Josh Schimmer from the Cantor biotech equity research team. And very pleased to introduce from Olema pharmaceuticals, we have Sean Bowen, President and Chief Executive Officer.
Questions & Answers
So let's kick it off by talking about a SERD and an estrogen inhibitor and some of the terminology as we think about playing into ER-positive breast cancer.
Yeah, great. Thank you. Thank you, Josh, and thank you for the opportunity on behalf of Olema. Yeah so, the concept here is pretty simple, right?
The estrogen receptor serves as a growth factor for breast tissue. And when you think about that in the simplest physiological way as a young woman going through puberty,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
